1. A population-level investigation of cancer clinical trials participation in a UK region
- Author
-
Anna Gavin, Jingwen J. Chen, Richard H. Wilson, Amy Devlin, Victoria Cairnduff, Conan Donnelly, Amy C. Wotherspoon, Eileen Morgan, and Melanie Morris
- Subjects
Adult ,Male ,Cancer Research ,medicine.medical_specialty ,Multivariate analysis ,Adolescent ,Epidemiology ,Population ,Northern Ireland ,Disease ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Neoplasms ,medicine ,Humans ,Registries ,030212 general & internal medicine ,Child ,education ,Aged ,Clinical Trials as Topic ,education.field_of_study ,business.industry ,Public Health, Environmental and Occupational Health ,Cancer ,Middle Aged ,medicine.disease ,United Kingdom ,Cancer registry ,Clinical trial ,Oncology ,Child, Preschool ,Population Surveillance ,030220 oncology & carcinogenesis ,Cohort ,Physical therapy ,Marital status ,Female ,Patient Participation ,business ,Demography - Abstract
The aim of this study was to document cancer trial participation since establishment of the Northern Ireland Cancer Trials Network and investigate population and disease factors associated with trial participation. An independent cohort of over 51 000 cancer patients from the Northern Ireland Cancer Registry covering the same population (2007-2012) was linked to a database of 1316 interventional cancer trial participants in a UK region. The primary outcome measure was participation in an intervention clinical trial. Patients were followed up until 31 March 2013. Kaplan-Meier tests and Cox proportional hazard models using person days at risk to allow for death were used to investigate factors associated with trial participation. Multivariate analysis assessed the impact of age, cancer type and stage, distance from the cancer centre (radiotherapy), marital status, deprivation quintile and rurality. Participation was analysed separately for children (
- Published
- 2017
- Full Text
- View/download PDF